ClinicalTrials.Veeva

Menu

Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin (LIFT)

University of Pennsylvania logo

University of Pennsylvania

Status

Enrolling

Conditions

Labor Induction
Cesarean Delivery

Treatments

Device: Foley balloon
Drug: Oxytocin

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

A randomized trial of patients undergoing a term (≥37 weeks) induction of labor with a history of one prior Cesarean delivery, wherein the provider intends to use a Foley catheter for cervical ripening. The investigators will be comparing Foley alone with concurrent Foley and Oxytocin use at the start of the induction. With this trial, the investigators aim to test our central hypothesis that concurrent Foley and Oxytocin will decrease time to delivery without increasing risks, compared to Foley alone.

Enrollment

100 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Eligible for induction of labor
  • Live singleton gestation ≥37 weeks
  • History of 1 cesarean delivery
  • ≥18 years of age
  • Cephalic presentation
  • Intact membranes
  • English or Spanish speaking (Able to read/understand consent and instructions)
  • Cervical dilation <3cm and Bishop score <8

Exclusion criteria

  • >1 prior Cesarean delivery
  • Known chorioamnionitis
  • Major fetal anomaly

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Concurrent Foley balloon and Oxytocin
Experimental group
Description:
Cervical ripening will begin with a Foley balloon and concurrent oxytocin, started within 2 hour of balloon placement
Treatment:
Drug: Oxytocin
Device: Foley balloon
Foley balloon alone
Active Comparator group
Description:
Cervical ripening will begin with a Foley balloon alone. Oxytocin will not be started until the balloon is removed or expelled, though can be considered if the balloon remains in place for \>8 hours
Treatment:
Device: Foley balloon

Trial contacts and locations

1

Loading...

Central trial contact

Hannah Foster, MD, MAUB

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems